Van Damme P - Search Results

1

Van Damme P, Beutels P. Van Damme P, et al. Pharmacoeconomics. 1996;9 Suppl 3:8-15; discussion 23-5. doi: 10.2165/00019053-199600093-00005. Pharmacoeconomics. 1996. PMID: 10160494

2

Hepatitis B prevention in Europe: a preliminary economic evaluation.

Van Damme P, Tormans G, Beutels P, Van Doorslaer E. Van Damme P, et al. Among authors: van doorslaer e. Vaccine. 1995;13 Suppl 1:S54-7. doi: 10.1016/0264-410x(95)93549-o. Vaccine. 1995. PMID: 7571833 Free article.

3

Costs and benefits of routine varicella vaccination in German children.

Beutels P, Clara R, Tormans G, Van Doorslaer E, Van Damme P. Beutels P, et al. Among authors: van doorslaer e, van damme p. J Infect Dis. 1996 Nov;174 Suppl 3:S335-41. doi: 10.1093/infdis/174.supplement_3.s335. J Infect Dis. 1996. PMID: 8896542

4

Cost effectiveness of alternative hepatitis A immunisation strategies.

van Doorslaer E, Tormans G, van Damme P, Beutels P. van Doorslaer E, et al. Among authors: van damme p. Pharmacoeconomics. 1995 Jul;8(1):5-8. doi: 10.2165/00019053-199508010-00002. Pharmacoeconomics. 1995. PMID: 10155602 No abstract available.

5

Economic evaluations of pneumococcal vaccination strategies in adults. A summary of the results.

Thiry N, Beutels P, Van Damme P. Thiry N, et al. Among authors: van damme p. Acta Clin Belg. 2005 Nov-Dec;60(6):338-44. doi: 10.1179/acb.2005.051. Acta Clin Belg. 2005. PMID: 16502594 Review.

6

Hepatitis A infection in aircrews: risk of infection and cost-benefit analysis of hepatitis A vaccination.

Gutersohn T, Steffen R, Van Damme P, Holdener F, Beutels P. Gutersohn T, et al. Among authors: van damme p. Aviat Space Environ Med. 1996 Feb;67(2):153-6. Aviat Space Environ Med. 1996. PMID: 8834941

7

An economic evaluation of hepatitis A vaccination in Dutch military personnel.

Buma AH, Beutels P, van Damme P, Tormans G, van Doorslaer E, Leentvaar-Kuijpers A. Buma AH, et al. Among authors: van doorslaer e, van damme p. Mil Med. 1998 Aug;163(8):564-7. Mil Med. 1998. PMID: 9715622

8

Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines.

Van Herck K, Beutels P, Van Damme P, Beutels M, Van den Dries J, Briantais P, Vidor E. Van Herck K, et al. Among authors: van damme p, van den dries j. J Med Virol. 2000 Jan;60(1):1-7. J Med Virol. 2000. PMID: 10568755 Clinical Trial.

9

The disease burden of hepatitis B in Uzbekistan.

Beutels P, Musabaev EI, Van Damme P, Yasin T. Beutels P, et al. Among authors: van damme p. J Infect. 2000 May;40(3):234-41. doi: 10.1053/jinf.1998.0666. J Infect. 2000. PMID: 10908017

10

The difficult quest for data on "vanishing" vaccine-preventable infections in Europe: the case of measles in Flanders (Belgium).

Beutels P, Van Damme P, Van Casteren V, Gay NJ, De Schrijver K, Meheus A. Beutels P, et al. Among authors: van casteren v, van damme p. Vaccine. 2002 Oct 4;20(29-30):3551-9. doi: 10.1016/s0264-410x(02)00335-3. Vaccine. 2002. PMID: 12297401

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,260 results

Search Page

Filters